Clinical studies recruiting near Clayton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Phase 3 · Monash Health ( Site 1004) · Merck Sharp & Dohme LLC · NCT06351631 Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Monash Clinical Research · Saluda Medical Pty Ltd · NCT04662905 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Australian and New Zealand Children's Haematology/Oncology G · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · Monash Medical Centre · Yonsei University · NCT06023862 Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · Monash Health · University of Melbourne · NCT07055542 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Monash Health - Monash Medical Centre - Clayton /ID# 272234 · AbbVie · NCT06682988 The DRAGON 2 Trial
NA · Monash Medical Centre · Maastricht University · NCT05428735 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Monash Health · Relay Therapeutics, Inc. · NCT06789913 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Monash Health · Hoffmann-La Roche · NCT06793215 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Monash Medical Center-Clayton Campus · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Victorian Heart Hospital · Amgen · NCT07037433 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Monash Health · Pfizer · NCT07421700 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · Monash Medical Centre · Monash University · NCT05678621 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Alliance for Clinical Trials in Oncology · NCT07091617 A Platform Trial for Gram Negative Bloodstream Infections
NA · Monash Medical Center · Sunnybrook Health Sciences Centre · NCT06537609 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Monash Children's Hospital · University of California, San Francisco · NCT05009992 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Eli Lilly and Company · NCT07369011 A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · Monash Health ( Site 0452) · Merck Sharp & Dohme LLC · NCT07247110 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Monash Medical Centre · Amgen · NCT04221542 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07357727 A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced
Phase 1/Phase 2 · Monash Health · BioNTech SE · NCT07186842 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Monash Medical Center-Clayton Campus · Children's Oncology Group · NCT04322318 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Monash Health, Monash Medical Centre · Gilead Sciences · NCT06051617 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Monash Medical Centre · Amgen · NCT07005128 A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Soli
Phase 1 · Monash Health · BeOne Medicines · NCT07181681 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Monash Health · Biogen · NCT06962800 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327 Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Phase N/A · School of Clinical Sciences at Monash Health, Faculty of Med · Monash University · NCT03138941

Look up another city

Look up another condition